Abstract

Dicyclohexylcarbodiimide (DCCD), a potent inhibitor of the F 0F 1-type H +-translocating ATPase, was employed to determine the possible involvement of such an ATPase in urinary acidification. Two methods were used in this approach: (1) the reaction of [ 14C]DCCD with tissues involved in urinary acidification and (2) the inhibition of ATPase activity by DCCD. Membrane components from epithelial cells of toad and turtle urinary bladder and brush borders of rabbit kidney were reacted with [ 14C]DCCD and analyzed by polyacrylamide gel electrophoresis both before and after extraction with organic solvents. Although a DCCD-binding component was extracted from toad and turtle bladder membranes by chloroform/methanol (2:1, v v ), the binding was not saturable. Analysis of this DCCD-binding component by thin-layer chromatography indicated that there was no ninhydrin reactivity associated with the [ 14C]DCCD binding. Moreover, all attempts to precipitate a DCCD-binding protein were unsuccessful. This and other evidence suggested that the observed DCCD binding was to phospholipid. In the second type of experiments, the ATPase activity present in brush borders from rabbit kidney was partially inhibited by DCCD, but at a concentration that is over two orders of magnitude greater than that required for typical DCCD-sensitive ATPase. We conclude from our failure to find positive evidence of a DCCD-reactive protein and from the relative insensitivity of the ATPase to DCCD that either urinary acidification is not accomplished by a typical F 0F 1-type translocating ATPase, or the F 0 has been modified so that the sensitivity to DCCD has been altered or lost.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call